Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P Biotech ETF
XBI
|
+$284M |
| 2 |
Constellation Brands
STZ
|
+$284M |
| 3 |
Stellantis
STLA
|
+$268M |
| 4 |
VMW
VMware, Inc
VMW
|
+$263M |
| 5 |
NiSource
NI
|
+$234M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.82B |
| 2 |
Apple
AAPL
|
+$1.62B |
| 3 |
UnitedHealth
UNH
|
+$1.03B |
| 4 |
ExxonMobil
XOM
|
+$869M |
| 5 |
Tesla
TSLA
|
+$701M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.19% |
| 2 | Consumer Discretionary | 5.03% |
| 3 | Healthcare | 4.78% |
| 4 | Financials | 4.74% |
| 5 | Communication Services | 2.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3351
Asure Software
ASUR
$251M
| $381K | ﹤0.01% |
+26,257
| New | +$310K |
|
3352
BioLife Solutions
BLFS
$1.57B
| $380K | ﹤0.01% |
17,460
+1,050
| +6% | +$23.6K |
|
|
CLPR
3353
Clipper Realty
CLPR
$44.6M
| $378K | ﹤0.01% |
65,895
+3,634
| +6% | +$24.1K |
|
|
GRCL
3354
DELISTED
Gracell Biotechnologies Inc. American Depositary Shares
GRCL
| $376K | ﹤0.01% |
202,325
+116,216
| +135% | +$243K |
|
3355
Gogo Inc
GOGO
$606M
| $375K | ﹤0.01% |
25,895
-1,451
| -5% | -$22.6K |
|
3356
Clean Energy Fuels
CLNE
$410M
| $375K | ﹤0.01% |
86,112
-40,210
| -32% | -$208K |
|
3357
Consensus Cloud Solutions
CCSI
$692M
| $375K | ﹤0.01% |
11,005
+2,145
| +24% | +$103K |
|
3358
Procept Biorobotics
PRCT
$1.06B
| $375K | ﹤0.01% |
13,208
+6,248
| +90% | +$220K |
|
|
OLO
3359
DELISTED
Olo Inc
OLO
| $374K | ﹤0.01% |
45,840
+21,692
| +90% | +$167K |
|
3360
iRadimed
IRMD
$1.17B
| $374K | ﹤0.01% |
9,502
+1,856
| +24% | +$67.5K |
|
3361
Omeros
OMER
$891M
| $374K | ﹤0.01% |
80,406
+50,349
| +168% | +$182K |
|
3362
PIMCO 25+ Year Zero Coupon US Treasury Index Exchange-Traded Fund
ZROZ
$1.27B
| $374K | ﹤0.01% |
3,900
+2,400
| +160% | +$225K |
|
3363
Nuvation Bio
NUVB
$2.18B
| $373K | ﹤0.01% |
224,478
+156,016
| +228% | +$316K |
|
3364
First Watch Restaurant Group
FWRG
$773M
| $372K | ﹤0.01% |
23,159
+8,433
| +57% | +$132K |
|
|
CTO
3365
CTO Realty Growth
CTO
$823M
| $371K | ﹤0.01% |
21,503
+6,399
| +42% | +$116K |
|
3366
Enact Holdings
ACT
$6.69B
| $371K | ﹤0.01% |
16,212
-15,275
| -49% | -$364K |
|
3367
Repay Holdings
RPAY
$339M
| $370K | ﹤0.01% |
56,391
+22,484
| +66% | +$185K |
|
|
ZEUS
3368
DELISTED
Olympic Steel
ZEUS
| $370K | ﹤0.01% |
7,085
-12,577
| -64% | -$581K |
|
3369
Sprott Physical Gold and Silver Trust
CEF
$7.42B
| $370K | ﹤0.01% |
19,561
| – | – |
|
3370
Dyne Therapeutics
DYN
$4.69B
| $370K | ﹤0.01% |
32,088
+7,845
| +32% | +$102K |
|
|
TIGR
3371
UP Fintech Holding
TIGR
$868M
| $369K | ﹤0.01% |
110,776
| – | – |
|
3372
First Bancorp
FNLC
$400M
| $369K | ﹤0.01% |
14,247
+2,287
| +19% | +$65.7K |
|
3373
Gray Television
GTN
$437M
| $369K | ﹤0.01% |
42,274
+20,231
| +92% | +$226K |
|
|
PLYA
3374
DELISTED
Playa Hotels & Resorts
PLYA
| $368K | ﹤0.01% |
38,315
-131,173
| -77% | -$1.05M |
|
|
PXD
3375
CALL
DELISTED
Pioneer Natural Resource Co.
PXD
| $368K | ﹤0.01% |
+1,800
| New | +$387K |
|
Similar funds
Barclays's Q1 2023 Portfolio in Review
As of Q1 2023, Barclays held 5,603 positions worth $218B, down 2.4% from $223B the previous quarter. Its ten largest holdings account for 47% of the portfolio.
Barclays withdrew a net $25.1B in Q1 2023, closing 541 positions and reducing 1,667 holdings. Its most notable exit was Coupa Software Incorporated, an estimated $128M position sold in full.
By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 12% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, Barclays opened a new position in GE HealthCare worth $40.7M.
- Barclays's largest Q1 2023 buy was GE HealthCare: 496,712 shares worth $40.7M.
- Barclays added most to State Street SPDR S&P Biotech ETF in Q1 2023, an estimated $284M increase.
- Barclays's biggest Q1 2023 reduction was Microsoft, cutting an estimated $1.82B.
- Barclays fully exited Coupa Software Incorporated in Q1 2023, selling an estimated $128M.
- Barclays's ten largest holdings make up 47% of its $218B portfolio in Q1 2023.
- Barclays opened 345 new positions and closed 541 in Q1 2023.
- Barclays's portfolio value fell 2.4% quarter-over-quarter to $218B.
Based on Barclays's 13F filing for Q1 2023, filed 4 May 2023.